Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuing Care01:25

Continuing Care

2.1K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.1K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.7K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.7K
Ethical Issues01:27

Ethical Issues

2.5K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

853
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
853
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

10.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Surrogate Decision-Makers' Perspectives on the American Thoracic Society and Society for Critical Care Medicine Statement on Shared Decision-Making in ICUs.

CHEST critical care·2026
Same author

<i>Letter:</i> End-of-Life Experience of Patients Planned for Organ Donation after Circulatory Death.

Journal of palliative medicine·2026
Same author

A multicenter, ethnographic study of interprofessional support for families facing goals of care decisions in intensive care units.

Annals of the American Thoracic Society·2026
Same author

Patterns of Referral to Embedded Palliative Care and Impact of Timing on End-of-Life Outcomes.

Journal of pain and symptom management·2026
Same author

Using Serious Games to Increase the Implementation of Trauma Triage Guidelines: A Randomized Clinical Trial.

JAMA·2026
Same author

Surrogate Perspectives on the Communication and Support Processes That Enable Them as Active Decision-Makers Across Chronic Critical Illness.

CHEST critical care·2026

Related Experiment Video

Updated: Apr 16, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.5K

Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study.

Thomas W LeBlanc1, Jonathan D O'Donnell2, Megan Crowley-Matoka2

  • 1Duke University School of Medicine; Duke Clinical Research Institute, Durham, NC; Northwestern University Feinberg School of Medicine, Chicago, IL; University of California San Francisco, San Francisco, CA; Icahn School of Medicine at Mount Sinai, New York, NY; and University of Pittsburgh, Pittsburgh, PA thomas.leblanc@duke.edu.

Journal of Oncology Practice
|March 19, 2015
PubMed
Summary

Hematologic oncologists view palliative care as end-of-life care, unlike solid tumor oncologists who see it as a subspecialty. Addressing unique barriers is key to integrating palliative care for hematologic malignancy patients.

Related Experiment Videos

Last Updated: Apr 16, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.5K

Area of Science:

  • Oncology
  • Palliative Care
  • Health Services Research

Background:

  • Patients with hematologic malignancies receive specialist palliative care less often than those with solid tumors.
  • The reasons for this disparity in palliative care utilization are not well understood.

Purpose of the Study:

  • To understand and contrast the perceptions of palliative care among oncologists treating hematologic malignancies versus solid tumors.
  • To identify barriers and facilitators to palliative care referral in these distinct patient populations.

Main Methods:

  • A multisite, mixed-methods study involving surveys and semistructured interviews with oncologists.
  • Quantitative analysis of referral patterns and qualitative analysis of perceptions and barriers.
  • Comparison of palliative care referral practices and views between hematologic and solid tumor oncologists.

Main Results:

  • 30% of hematologic oncologists never referred patients to palliative care, compared to 0% of solid tumor oncologists.
  • Hematologic oncologists predominantly viewed palliative care as end-of-life care, while solid tumor oncologists saw it as a resource for complex cases.
  • Hematologic oncologists cited philosophic concerns (treatment goals, chemotherapy responsiveness) and control over care, whereas solid tumor oncologists noted practical barriers (appointment availability, reimbursement).

Conclusions:

  • Significant differences exist in how hematologic and solid tumor oncologists perceive and utilize palliative care.
  • Hematologic oncologists' view of palliative care as solely end-of-life care presents a barrier to integration.
  • Tailored strategies addressing the specific concerns of hematologic oncologists are necessary to improve palliative care access for these patients.